Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Nervous SystemDRG 063-ischemic-stroke-precerebral-occlusion-or-transient-ischemia-with-thrombolytic-agent-without-cc-mcc
    Ask Trek AI about this page

    Ischemic Stroke with Thrombolytic Agent: Inpatient Reimbursement Overview

    DRG 063 addresses ischemic stroke, precerebral occlusion, or transient ischemia treated with a thrombolytic agent without Major Complication or Comorbidity or Complication or Comorbidity. This category defines inpatient resource use and influences Medicare Severity Diagnosis-Related Group–based payment for acute cerebrovascular care.

    Customize your policy alerts

    Sign up for drg 063 policy alerts

    Get alerted when payer policies referencing 063 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 063 Overview

    DRG 063 covers inpatient admissions for ischemic stroke, precerebral occlusion, or transient ischemia where a thrombolytic agent was administered and there is no Major Complication or Comorbidity and no Complication or Comorbidity. This grouping reflects cases requiring acute cerebrovascular intervention with thrombolysis but without additional complicating diagnoses. It matters for Medicare payment because the presence of thrombolytic therapy and the absence of higher-severity comorbid conditions drive relative resource use and reimbursement within the Diagnosis-Related Group system. Accurate clinical documentation and coding determine assignment to this Diagnosis-Related Group and the associated inpatient payment classification.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute reperfusion and thrombolytic optimization studies: These trials investigate timing, dosing strategies, adjunctive anticoagulant or antiplatelet use, and protocolized workflows for administering thrombolytic agents in patients presenting with acute ischemic stroke or transient ischemic attack due to precerebral occlusion. The patient population includes adults arriving within the therapeutic time window with imaging-confirmed large-artery or precerebral stenosis/occlusion eligible for intravenous thrombolysis; studies often measure reperfusion rates, early neurological improvement, and in-hospital complications. Findings are highly relevant to clinicians determining acute management protocols and to payers because optimized acute care can shorten length of stay, reduce complication-related costs, and influence DRG resource utilization.
    • Comparative effectiveness and safety studies of reperfusion pathways: These comparative studies evaluate different acute-care pathways such as primary thrombolysis alone versus combined approaches (system-level triage to endovascular-capable centers, or standardized thrombolysis-plus-early-transfer protocols) in similar patient cohorts with precerebral occlusive disease. They enroll real-world inpatient populations admitted under this DRG to assess outcomes like functional status at discharge, rates of hemorrhagic transformation, need for secondary interventions, and resource use across hospitals. Results inform hospital-level decisions about transfer policies, resource allocation, and payer contracting because they clarify which care pathways yield better outcomes for similar or lower costs in this tracer population.
    • Post-discharge secondary prevention and readmission reduction trials: These studies target the early post-acute period for patients who received thrombolytic therapy for ischemic stroke or transient ischemia due to precerebral disease, testing interventions such as structured secondary prevention clinics, telehealth follow-up, medication-reconciliation programs, and risk-factor management bundles. The enrolled population comprises survivors discharged from the index hospitalization under this DRG who are at risk for recurrent stroke, treatment complications, or readmission; endpoints include 30- and 90-day readmission rates, adherence to antithrombotic therapies, and functional recovery. For providers and payers, evidence from these trials is valuable because effective post-discharge programs can reduce readmissions and downstream costs, improve quality metrics, and affect overall reimbursement and case-mix-adjusted outcomes for institutions.

    Related Codes

    020-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITH-MCC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage with MCC: Inpatient Reimbursement Overview

    021-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITH-CC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage with CC: Inpatient Reimbursement Overview

    022-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITHOUT-CC-MCC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage without CC/MCC: Inpatient Reimbursement Overview

    023-CRANIOTOMY-WITH-MAJOR-DEVICE-IMPLANT-OR-ACUTE-COMPLEX-CNS-PRINCIPAL-DIAGNOSIS-WITH-MCC-OR-ANTINEOPLASTIC-IMPLANT-OR-EPILEPSY-WITH-NEUROSTIMULATOR

    Craniotomy with Major Device Implant or Complex CNS DRG 023: Inpatient Reimbursement Overview

    024-CRANIOTOMY-WITH-MAJOR-DEVICE-IMPLANT-OR-ACUTE-COMPLEX-CNS-PRINCIPAL-DIAGNOSIS-WITHOUT-MCC

    Craniotomy with Major Device Implant or Acute Complex CNS Principal Diagnosis without MCC: Inpatient Reimbursement Overview

    025-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITH-MCC

    Craniotomy and Endovascular Intracranial Procedures with MCC: Inpatient Reimbursement Overview

    026-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITH-CC

    Craniotomy and Endovascular Intracranial Procedures with CC: Inpatient Reimbursement Overview

    027-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITHOUT-CC-MCC

    Craniotomy and Endovascular Intracranial Procedures without CC/MCC: Inpatient Reimbursement Overview

    028-SPINAL-PROCEDURES-WITH-MCC

    Spinal Procedures with MCC: Inpatient Reimbursement Overview

    029-SPINAL-PROCEDURES-WITH-CC-OR-SPINAL-NEUROSTIMULATORS

    Spinal Procedures with CC or Spinal Neurostimulators: Inpatient Reimbursement Overview

    Showing 1–10 of 71

    • More pages

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.